Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now?
Is NVO a good stock to buy? We came across a bullish thesis on Novo Nordisk A/S on Unfair Advantage’s Substack by AK. In this article, we will summarize the bulls’ thesis on NVO.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 9,021,103 | $331,525,592 | -8% | 0.11% |
| 2. | Markel Gayner Asset Management Tom Gayner | 2,869,774 | $105,464,196 | 0.88% | |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 16,524 | $607,257 | +683% | 0% |
| 4. | Hurley Capital Charles Goldblum | 6 | $221 | 0% | |
| 5. | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,565,708 | $167,789,769 | 0.03% | |
| 2. | 3,959,430 | $145,509,068 | 0.04% | |
| 3. | 3,436,329 | $126,285,091 | 7.17% | |
| 4. | Ubs Group AgPUT | 2,843,100 | $104,483,925 | 0.02% |
| 5. | Imc-chicago, LlcCALL | 2,086,200 | $76,667,850 | 0.03% |